voluntary suspension, page-13

I am guessing the capital raising is either:

1. To finance the (now approved?) Anheal aquisition.

2. To fund the expansion of Pepp into new markets.

Either way, I expect the majority of the money to come from Chinese or Singaporean sophisticated investors and/or a large pharmaceutical wanting to secure a distribution agreement.
Shareholders will be able to participate on a "1 for 1" basis as a reward for their patience, before RBY is reinstated and the share price hits an all time high.